RxDoctor Payments Data

Melanie Lyon

Nurse Practitioner · Grand Rapids, MINPI 1699436592

Payments from drug & device makers

$3,226in general payments, 2019–2025

Across 153 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$478
  • AstraZeneca$398
  • Amgen$318
  • Calliditas Therapeutics US Inc.$304
  • Aurinia Pharma U.S., Inc.$231
  • Novo Nordisk$194
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,07495%
  • Education$1525%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,226 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide12$37,730
FarxigaDapagliflozin Propanediol32$26,140
AuryxiaFerric Citrate16$22,361
KerendiaFinerenone31$19,619
Sevelamer Carbonate78$12,050
ClinolipidFat Emulsion/Olive/Soy/Phospho26$6,681
Calcium Acetate32$2,735
Calcitriol109$1,856
Torsemide65$1,515
Losartan Potassium69$817
Carvedilol66$731
Midodrine Hcl14$642
Lisinopril60$575
Amlodipine Besylate81$467
Hydralazine Hcl21$219

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$72$37,73012 claims
AstraZenecaFarxiga$398$26,14032 claims
Akebia Therapeutics IncAuryxia$23$22,36116 claims
BayerKerendia$163$19,61931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →